LactoStop Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

LactoStop General Information

Description

Developer of anti-lactose intolerant medicine intended to enable people with a lactose intolerance to enjoy milk products. The company's anti-lactose intolerant medicine replaces the body-specific lactase lacking in lactose-intolerant individuals, enabling patients to avail high-quality natural products, food supplements and medical products.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Dermapharm
Primary Office
  • Am Haag 14
  • 82166 Gräfelfing
  • Germany
+49 089 000000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

LactoStop Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore LactoStop‘s full profile, request access.

Request a free trial

LactoStop Executive Team (1)

Name Title Board Seat Contact Info
Clemens Fischer Ph.D Chief Executive Officer
To view LactoStop’s complete executive team members history, request access »

LactoStop Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore LactoStop‘s full profile, request access.

Request a free trial